PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Regeneron Pharmaceuticals stock at 5.20%, Amgen at 5.15%, Vertex Pharmaceuticals at 4.94%, Royalty Pharma at 4.89%, and Biogen at 4.81%.

Total Holdings

Top 10 Percentage

44.84%

Asset Class

Equity

ETF Category

Health

Assets

346.62M

PE Ratio

22.18

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	REGN	Regeneron Pharmaceuticals, Inc.	5.20%	20,233
2	AMGN	Amgen Inc.	5.15%	38,223
3	VRTX	Vertex Pharmaceuticals Incorporated	4.94%	29,460
4	RPRX	Royalty Pharma plc	4.89%	238,422
5	BIIB	Biogen Inc.	4.81%	66,507
6	GILD	Gilead Sciences, Inc.	4.38%	96,026
7	CDNA	CareDx, Inc.	4.31%	325,179
8	UTHR	United Therapeutics Corporation	4.06%	22,197
9	TECH	Bio-Techne Corporation	3.66%	146,019
10	ILMN	Illumina, Inc.	3.44%	48,231
11	PTGX	Protagonist Therapeutics, Inc.	3.38%	70,055
12	VCEL	Vericel Corporation	3.32%	200,298
13	VCYT	Veracyte, Inc.	3.29%	158,435
14	ALNY	Alnylam Pharmaceuticals, Inc.	3.11%	43,457
15	INCY	Incyte Corporation	3.09%	72,136
16	ACAD	ACADIA Pharmaceuticals Inc.	3.04%	329,464
17	RGEN	Repligen Corporation	3.04%	60,807
18	HALO	Halozyme Therapeutics, Inc.	2.95%	101,929
19	NBIX	Neurocrine Biosciences, Inc.	2.90%	44,979
20	QGEN	Qiagen N.V.	2.84%	197,087
21	BMRN	BioMarin Pharmaceutical Inc.	2.79%	132,461
22	EXEL	Exelixis, Inc.	2.73%	140,144
23	PTCT	PTC Therapeutics, Inc.	2.72%	103,541
24	BCRX	BioCryst Pharmaceuticals, Inc.	2.66%	826,963
25	COLL	Collegium Pharmaceutical, Inc.	2.60%	207,352

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Jul 30, 2026